Cutera, Inc. (NASDAQ:CUTR) Q2 2020 Earnings Conference Call - Final Transcript

Aug 06, 2020 • 04:30 pm ET


Cutera, Inc. (NASDAQ:CUTR) Q2 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Thank you for joining Cutera's Second Quarter 2020 Earnings Conference Call. After the prepared remarks, there will be a question-and-answer session. The discussion today includes forward-looking statements. These forward-looking statements reflect management's current forecast or expectation of certain aspects of the company's future business, including, but not limited to, any financial guidance provided for modeling purposes.

Forward-looking statements are based on current information that is by its nature dynamic and subject to change. Forward-looking statements include, among others, statements regarding financial guidance, plans to introduce new products, regulatory approvals and productivity improvements. For words that may identify forward approval -- for words that may identify forward-looking statements, we encourage you to refer to the safe harbor statement in our press release earlier today.

All forward-looking statements are subject to risk and uncertainties, including those risk factors described in the section entitled Risk Factors in our Form 10-K as filed with the Securities and Exchange Commission and updated in our Form 10-Q subsequently filed. Cutera also cautions you not to place undue reliance on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances or to reflect the occurrence of unanticipated events. Future results may differ materially from management's current expectations.

In addition, we will discuss non-GAAP financial measures, including results on an adjusted basis. We believe these financial measures can facilitate a more complete analysis and greater transparency into Cutera's ongoing results of operations, particularly when comparing underlying results from period to period. Please refer to the reconciliation from GAAP to non-GAAP measures in our earnings release. These non-GAAP financial measures should be considered along with, but not as an alternative to, the operating performance measures prescribed by GAAP.

With that, I would like to turn the call over to your CEO, Dave Mowry.

David H. Mowry

Thank you, operator. As we all know, the second quarter of 2020 was significantly impacted by the COVID-19 pandemic. This unprecedented global crisis has affected all of us in some way, shape or form. As a member of the health care community, I would like to take a moment to express our appreciation for the many people who have sacrificed their own safety to provide care for those directly touched by the virus. The integrity, commitment and skill demonstrated by our first responders and acute care center staffs have been not only impressive, but also humbling to watch in the face of such adversity.

Today, I'm joined on the call by Jason Richey, President and Chief Operating Officer; as well as Fuad Ahmad, our Interim Chief Financial Officer. I will begin today's call by providing a brief overview of our second quarter 2020 business results, highlighting our efforts to mobilize around the customer while rightsizing our business to an evolving end market environment. Additionally, I will share our view of the pace and magnitude of the market recovery we expect to see over the back half of 2020